The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvi Japan Oppo. Regulatory News (AJOT)

Share Price Information for Avi Japan Oppo. (AJOT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 131.00
Bid: 129.50
Ask: 132.50
Change: 2.00 (1.55%)
Spread: 3.00 (2.317%)
Open: 131.00
High: 131.00
Low: 129.50
Prev. Close: 129.00
AJOT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New Research

14 Oct 2020 10:30

RNS Number : 0707C
AVI Japan Opportunity Trust PLC
14 October 2020
 

AVI Japan Opportunity: New research

14/10/2020

AJOT invests in Japanese small caps, taking advantage of extremely low valuations and using shareholder activism...

The investment companies team at Kepler Trust Intelligence has produced a new piece of investment bank quality research about the trust, designed to provide a clear and comprehensive reference for long term investors. This note is free to read for UK investors.

Click here to read the note in full.

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

 

 

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEANELFALEFEA
Date   Source Headline
4th Jul 20233:10 pmRNSAVI Shareholder Proposals Passed at NCHD’s AGM
4th Jul 202312:31 pmRNSNet Asset Value(s)
3rd Jul 20232:23 pmRNSNet Asset Value(s)
30th Jun 20234:04 pmRNSNet Asset Value(s)
29th Jun 202312:13 pmRNSNet Asset Value(s)
28th Jun 20232:25 pmRNSNet Asset Value(s)
27th Jun 20232:47 pmRNSNet Asset Value(s)
26th Jun 20234:11 pmRNSNet Asset Value(s)
23rd Jun 202312:16 pmRNSNet Asset Value(s)
22nd Jun 20233:41 pmRNSNet Asset Value(s)
21st Jun 20233:16 pmRNSNet Asset Value(s)
20th Jun 20231:01 pmRNSNet Asset Value(s)
19th Jun 202312:58 pmRNSNet Asset Value(s)
16th Jun 20232:22 pmRNSNet Asset Value(s)
15th Jun 202312:43 pmRNSNet Asset Value(s)
14th Jun 20231:25 pmRNSNet Asset Value(s)
13th Jun 20232:14 pmRNSNet Asset Value(s)
12th Jun 202312:56 pmRNSNet Asset Value(s)
9th Jun 20232:46 pmRNSNet Asset Value(s)
8th Jun 20232:12 pmRNSMonthly update
8th Jun 20231:46 pmRNSNet Asset Value(s)
7th Jun 20232:59 pmRNSNet Asset Value(s)
7th Jun 202311:18 amRNSDirector/PDMR Shareholding
7th Jun 202310:40 amRNSAVI’s Rebuttal to NCHD’s Opposition to Proposals
7th Jun 20237:00 amRNSAVI’s Rebuttal to NCHD’s Opposition to Proposals
6th Jun 202312:52 pmRNSNet Asset Value(s)
5th Jun 20233:25 pmRNSDirector/PDMR Shareholding
5th Jun 20232:43 pmRNSNet Asset Value(s)
2nd Jun 20232:27 pmRNSNet Asset Value(s)
1st Jun 20233:21 pmRNSNet Asset Value(s)
1st Jun 20239:00 amRNSTotal Voting Rights
31st May 20235:33 pmRNSIssue of Equity
31st May 20232:29 pmRNSNet Asset Value(s)
30th May 20234:49 pmRNSIssue of Equity
30th May 20232:10 pmRNSNet Asset Value(s)
26th May 20231:50 pmRNSNet Asset Value(s)
25th May 20232:18 pmRNSNet Asset Value(s)
24th May 20234:42 pmRNSNet Asset Value(s)
23rd May 20235:53 pmRNSIssue of Equity
23rd May 20232:10 pmRNSNet Asset Value(s)
22nd May 20231:32 pmRNSNet Asset Value(s)
19th May 20233:49 pmRNSNet Asset Value(s)
18th May 202312:36 pmRNSNet Asset Value(s)
18th May 20237:00 amRNSAVI submits shareholder proposals to NC Holdings
18th May 20237:00 amRNSAVI Submits Shareholder Proposals to SK Kaken
17th May 20231:11 pmRNSNet Asset Value(s)
16th May 20233:19 pmRNSNet Asset Value(s)
15th May 20232:10 pmRNSNet Asset Value(s)
12th May 20232:05 pmRNSNet Asset Value(s)
11th May 202312:07 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.